Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Bioelectronica Closes $16 Million Funding from China Investors

publication date: Feb 24, 2021

Bioelectronica of Reno, Nevada closed a $16 million Series A investment from two China investors, Proxima Ventures and Co-win Ventures, to support its novel drug discovery/development platform. Hypercell® is a single cell sorting platform that uses computer vision, data science and lensless imaging to enable single cell sorting assays with high throughput. Bioelectronica offers CRO services from novel assay development to scalable electrofluidics. The company believes its platform speeds up development and lowers costs. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital